Drug Monitoring of Sorafenib in Patients With Advanced Hepatocellular Carcinoma (DOSE-HEP)

This study is currently recruiting participants.
Verified February 2010 by South West Sydney Local Health District
Sponsor:
Information provided by:
South West Sydney Local Health District
ClinicalTrials.gov Identifier:
NCT01078311
First received: March 1, 2010
Last updated: NA
Last verified: February 2010
History: No changes posted
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: February 2014
  Estimated Primary Completion Date: February 2012 (Final data collection date for primary outcome measure)